BC Cancer
BC Cancer
Vancouver, British Columbia, Canada1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors | HR+, HER2-, Advanced Breast Cancer; Triple Negative Locally Advanced Non-resectable Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2025-09-24 | NCT06827613 |